Pancreatic Cancer Research

ResearcherJinan UniversityNo recent work listed

Kecheng Xu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100921224. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2012: 3 papers · 2013: 5 papers · 2014: none · 2015: none · 2016: none · 2017: 4 papers · 2018: 2 papers

Papers 14

  1. Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer. Last author DOI 10.1007/s12026-017-8959-2↗
  2. Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer. Co-author DOI 10.1159/000490874↗
  3. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic c… Last author DOI 10.1007/s00432-017-2513-4↗
  4. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cance… Last author DOI 10.1016/j.imlet.2017.03.018↗
  5. Clinical Practice Guidelines for Cryosurgery of Pancreatic Cancer: A Consensus Statement From the China Cooperative Group of Cryosurgery on Pancreatic Cancer, … Last author DOI 10.1097/mpa.0000000000000878↗
  6. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer. Last author DOI 10.18632/oncotarget.21974↗
  7. Alleviating visceral cancer pain in patients with pancreatic cancer using cryoablation and celiac plexus block. Last author DOI 10.1016/j.cryobiol.2012.12.002↗
  8. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. Last author DOI 10.1097/mpa.0b013e3182965dde↗
  9. Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery. Last author DOI 10.1186/1746-1596-8-146↗
  10. Cryosurgery for pancreatic cancer. Co-author DOI 10.3978/j.issn.2227-684x.2013.02.02↗
  11. Cryosurgery in combination with brachytherapy of iodine-125 seeds for pancreatic cancer. Co-author DOI 10.3978/j.issn.2227-684x.2013.04.04↗
  12. The establishment of the duplex real-time RT-PCR assay for the detection of CD44v6 in pancreatic cancer patients and clinical application. Last author DOI 10.1002/bab.69↗
  13. Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients. Last author DOI 10.1007/s10529-012-0908-5↗
  14. [Percutaneous cryoablation and (125)I seed implantation combined with chemotherapy for advanced pancreatic cancer: report of 67 cases]. Last author DOI 10.3760/cma.j.issn.0253-3766.2012.12.013↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lizhi Niu · 14 shared papers, 2012–2018 · strength 0.79
  2. Jibing Chen · 7 shared papers, 2013–2018 · strength 0.46
  3. Mao Lin · 5 shared papers, 2017–2018 · strength 0.39
  4. Mohammed Alnaggar · 3 shared papers, 2017–2018 · strength 0.25
  5. Lihua He · 5 shared papers, 2012–2017 · strength 0.21
  6. Gang Zhou · 3 shared papers, 2012–2013 · strength 0.11
  7. Daming Yang · 1 shared paper, 2013 · strength 0.06
  8. Yize Hu · 1 shared paper, 2013 · strength 0.05
  9. Li Zhang · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.